Bridging the Gap: Endothelial Dysfunction and the Role of iPSC-Derived Endothelial Cells in Disease Modeling
2024

Endothelial Dysfunction and iPSC-Derived Endothelial Cells in Disease Modeling

publication 10 minutes Evidence: moderate

Author Information

Author(s): Sgromo Chiara, Cucci Alessia, Venturin Giorgia, Follenzi Antonia, Olgasi Cristina

Primary Institution: University of Piemonte Orientale

Hypothesis

Induced pluripotent stem cells (iPSCs) can provide a renewable source of endothelial cells to study endothelial dysfunction (ED) in various diseases.

Conclusion

iPSC-derived endothelial cells can effectively model endothelial dysfunction and provide insights into the mechanisms underlying diseases like cardiovascular disorders, diabetes, and neurodegenerative diseases.

Supporting Evidence

  • Endothelial cells are crucial for vascular health and their dysfunction is linked to various diseases.
  • iPSC-derived endothelial cells provide a patient-specific model to study disease mechanisms.
  • Recent advancements in 3D models enhance the physiological relevance of iPSC-derived endothelial cells.

Takeaway

Scientists can create special cells from skin or blood that help them understand why blood vessels don't work well in diseases like diabetes and heart problems.

Methodology

This review summarizes the mechanisms of endothelial dysfunction and the applications of iPSC-derived endothelial cells in modeling various diseases.

Limitations

iPSC-derived endothelial cells may exhibit immature or heterogeneous phenotypes and require extensive validation for functionality.

Digital Object Identifier (DOI)

10.3390/ijms252413275

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication